NCT00268749View on ClinicalTrials.gov

Glycine Treatment of Prodromal Symptoms

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 31, 2002

Primary Completion Date

November 30, 2004

Study Completion Date

November 30, 2004

Conditions
Schizophrenia
Interventions
DRUG

glycine

0.8 g/kg/day

All Listed Sponsors
collaborator

Stanley Medical Research Institute

OTHER

lead

Yale University

OTHER

NCT00268749 - Glycine Treatment of Prodromal Symptoms | Biotech Hunter | Biotech Hunter